ProShares - Ultra Nasdaq Biotechnology
Not enough financial coverage to compute a composite score for BIB. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.proshares.com/our-etfs/leveraged-and-inverse/bib
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
- IPO
- 2010
- HQ
- Bethesda, MD, US
Price Chart
Valuation
- Market Cap
- $72.46M
- Div Yield
- 0.62%
Performance & Tape
- 52W High
- $90.91
- 52W Low
- $42.09
- 50D MA
- $81.73
- 200D MA
- $74.72
- Beta
- 1.16
- Avg Volume
- 11.02K
Get TickerSpark's AI analysis on BIB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIB Coverage
We haven't published any research on BIB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIB Report →